I gave a hold rating to Cellebrite (NASDAQ: CLBT ) in May, as I was worried about the valuation being too high relative to a mixed growth setup. When I last wrote about Cellebrite, I gave it aI'm a passionate investor with a strong foundation in fundamental analysis and a keen eye for identifying undervalued companies with long-term growth potential. My investment approach is a blend of value investing principles and a focus on long-term growth. I believe in buying quality companies at a discount to their i ...